Appeals – competition – abuse of a dominant position – market in anti-ulcer medicines – abuse of procedures relating to supplementary protection certificates for medicinal products and of marketing authorisation procedures for medicinal products – misleading representations – deregistration of marketing authorisations – obstacles to the marketing of generic medicinal products and to parallel imports.
